Anzeige
Meldung des Tages: Der Countdown zu einer der heißesten AI-Hightech-Stories 2026 beginnt jetzt

Elanco Animal Health Aktie News

Aktie
WKN:  A2N6BH ISIN:  US28414H1032 US-Symbol:  ELAN Branche:  Pharmazeutika Land:  USA
24,52 $
+0,44 $
+1,83%
20,803 € 19:24:34 Uhr
Depot/Watchlist
Marktkapitalisierung *
9,49 Mrd. €
Streubesitz
-
KGV
24,08
Index-Zuordnung
-

Elanco Animal Health News

24.07.25 - PR Newswire
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs PR Newswire
10.07.25 - PR Newswire
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement PR Newswire
09.07.25 - PR Newswire
Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection
Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection PR Newswire
26.06.25 - PR Newswire
Elanco Releases 2024 Impact Report and Introduces New Framework
Elanco Releases 2024 Impact Report and Introduces New Framework PR Newswire
12.06.25 - PR Newswire
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) PR Newswire
05.06.25 - PR Newswire
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief PR Newswire
28.05.25 - PR Newswire
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer PR Newswire
16.05.25 - PR Newswire
Elanco to Participate in the Upcoming Investor Conferences
Elanco to Participate in the Upcoming Investor Conferences PR Newswire
07.05.25 - PR Newswire
Elanco Animal Health Reports First Quarter 2025 Results
Elanco Animal Health Reports First Quarter 2025 Results PR Newswire
05.05.25 - PR Newswire
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown PR Newswire
22.04.25 - PR Newswire
Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day
Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus ...
10.04.25 - PR Newswire
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement PR Newswire
17.03.25 - PR Newswire
Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets
Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets PR Newswire
25.02.25 - PR Newswire
Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle
Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle PR Newswire
25.02.25 - PR Newswire
Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results
Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results PR Newswire
21.02.25 - PR Newswire
Elanco to Participate in Upcoming Investor Conferences
Elanco to Participate in Upcoming Investor Conferences PR Newswire
20.02.25 - PR Newswire
Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-Formulated Supplements for Complete Pet Wellness
Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-​Formulated Supplements for Complete Pet Wellness PR Newswire
13.02.25 - PR Newswire
Elanco Reinforces Commitment to Veterinary and Pet Owner Education
Elanco Reinforces Commitment to Veterinary and Pet Owner Education PR Newswire
04.02.25 - PR Newswire
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement PR Newswire

Newssuche

Videos

newspaper
12:40 Uhr +27,72%
Technical Trading Silber Crash!
Silber Short Typ: Turbo Open End WKN: VJ4GQU Hebel: 3,77 Laufzeit: OpenEnd Einstieg: Market ... Mehr »